Afleveringen
-
Professor Alex Ford is a renowned researcher in Gastroenterology, specializing in Disorders of Gut-Brain Interaction (DGBIs). Based at the University of Leeds, he has authored numerous high-impact studies on conditions like irritable bowel syndrome (IBS) and functional dyspepsia. With a focus on evidence-based treatments and advancing our understanding of the gut-brain axis, Professor Ford is widely recognized for his contributions to both clinical practice and academic research.
Summary
In this conversation, we interview Professor Ford about his work and insights into Disorders of Gut-Brain Interaction (DGBI). Alex explains the complexities of IBS, including its diagnosis, the role of the gut-brain axis, and the impact of symptoms on patients' quality of life. He discusses the diagnostic criteria for IBS, the significance of bile acid diarrhea, and various treatment approaches, including the use of gut-brain neuromodulators. The conversation also covers the ATLANTIS trial, which investigated the efficacy of amitriptyline in treating IBS in primary care, and touches on the concept of neuroplasticity in relation to long-term treatment effects. We go on to discuss the complexities of managing Irritable Bowel Syndrome (IBS), emphasizing the importance of psychological therapies, the nuances of treatment sequencing, and common mistakes made in IBS management. Professor Ford highlights the need for evidence-based approaches, the role of probiotics, and reflects on his academic career, stressing the importance of mentorship and the ability to discern valuable opportunities in one's professional journey.
Chapters
03:00 Introduction to Alex Ford and His Work
05:04 Understanding Irritable Bowel Syndrome (IBS)
11:22 Diagnostic Criteria for IBS
14:05 The Role of Bile Acid Diarrhoea
18:44 Treatment Approaches for IBS
20:06 The ATLANTIS Trial and Its Findings
30:07 Neuroplasticity and Long-term Effects of Neuromodulating agents
37:47 Neuromodulator titration and Psychological Therapies in IBS41:59 Sequencing Treatments for IBS
48:45 Common Mistakes in IBS Management
55:34 Probiotics: Evidence and Recommendations
59:56 Reflections on an Academic Career
Articles discussed:
ATLANTIS Trial: https://www.thelancet.com/article/S0140-6736(23)01523-4/fulltext
Probiotic meta-analysis: https://www.gastrojournal.org/article/S0016-5085(23)04838-2/fulltext
Follow us:
Twitter/X: https://x.com/2guystalkingit
-
Every podcast is incomplete without a 'best of' episode from the previous year. In this episode Jon and James talk about their big learnings / seminal papers / themes of 2024 in Gastroenterology and Hepatology.
We wish we could have included more!
As always, please leave questions/comments either below or on our X (@2guystalkingit).
-
Zijn er afleveringen die ontbreken?
-
Episode #02: Checkpoint conversations
In the first full episode, we tackle the rising challenge of managing colitis and hepatitis triggered by immune checkpoint inhibitors. From recognizing these entities to exploring (non) evidence-based management strategies. Join us for a conversation packed with insights, or if you just want to hear Jon try and pronounce 'nomenclature'.
Please leave any questions, comments, or suggestions either on our twitter feed (@2guystalkingit) or below. We will try to answer any listener questions on the next show.
-
Hello world..
Welcome to Two guys talking **it - a podcast designed for gastroenterologists and hepatologists or anyone interested in the field. Each week, join Jon and James as we bring you expert discussions, the latest research, and practical clinical insights amongst a lot of talking **it..
In this episode we briefly introduce the podcast. Bear with us as we try to work this thing out!
Please leave any comments or requests for future episodes, or catch us on twitter (@Jonathansegal85 or @JamesHaridy)
